"A medical oncology practice providing comprehensive and coordinated cancer care to patients needing medical treatment for cancer and blood disorders."

During the past decade, Southwest Oncology PC conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 45 clinical trials were completed, i.e. on average, 41.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 35 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southwest Oncology PC" #1 sponsor was "National Cancer Institute (NCI)" with 68 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Oncology PC" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Oncology PC" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Southwest Oncology PC" in a lesser frequency.

Most popular intervention types in "Southwest Oncology PC" are "Drug" (123 trials), "Other" (89 trials), "Biological" (67 trials), "Procedure" (42 trials) and "Radiation" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (37 trials), "Computed Tomography" (26 trials), "Questionnaire Administration" (25 trials) and "Biospecimen Collection" (24 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Oncology PC" are 127 trials for "All" genders, 22 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Southwest Oncology PC". undefined are not yet recruiting, 53 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Southwest Oncology PC, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Oncology PC, 4 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".